参考文献/References:
[1] PAPADOPOULOU-MARKETOU N, KANAKAGANTENBEINC, MARKETOS N, et al. Biomarkersof diabetic nephropathy: A 2017 update[J].Crit RevClin Lab Sci,2017,54(5):326-342.
[2] 中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏疾病防治临床指南[J]. 中华糖尿病杂志,2019, 11（1）, 15-28. The Microvascular Complications Group of ChineseDiabetes Association. Chinese clinical practice guidelineof diabetic kidney disease[J].Chinese Journal ofDiabetes Mellitus，2019, 11（1）, 15-28.
[3] PARK S B, KIM S S,KIM Y K ,et al. Variabilityin glycated albumin levels predicts the progressionof diabetic nephropathy[J]. J Diabetes Complications,2017,31(6):1041-1046.
[4] BALMER L A, WHITING R, RUDNICKA C, et al.Genetic characterization of early renal changes ina novel mouse model of diabetic kidney disease[J].Kidney International, 2019,96(4):918-926.
[5] ALICIC R Z, ROONEY M T, TUTTLE K R. DiabeticKidney Disease:Challenges, Progress, and Possibilities[J].Clin J Am Soc Nephrol,2017,12(12):2032-2045.
[6] KIM H K, KIM J E, PARK S H, et al. Highcoagulation factor levels and low protein C levelscontribute to enhanced thrombin generation inpatients with diabetes who do not have macrovascularcomplications[J]. Journal of Diabetes and Its Complications,2014,28(3):365-369.
[7] PAN Lianlian, YE Yali, WO Mingyi ,et al. ClinicalSignificance of Hemostatic Parameters in thePrediction for Type 2 Diabetes Mellitus and DiabeticNephropathy[J].Disease Markers,2018, 2018:5214376.
[8] EBARA S, MARUMO M , YAMABATA C, et al.Inverse associations of HDL cholesterol and oxidizedHDL with D-dimer in patients with type 2 diabetesmellitus[J].Thrombosis Research,2017,155:12-15.
[9] STEVENS P E, LEVIN A. Evaluation and Managementof Chronic Kidney Disease: Synopsis of theKidney Disease: Improving Global Outcomes 2012Clinical Practice Guideline. Annals of Internal Medicine,2013,158(11):825-830.
[10] PERSSON F, ROSSING P. Diagnosis of diabetickidney disease: state of the art and future perspective[J].Kidney Int Suppl,2018,8(1):2-7.
[11] RETNAKARAN R, CULL C A, THORNE K I, et al.Risk factors for renal dysfunction in type 2 diabetes:U.K. Prospective Diabetes Study 74[J].Diabetes,2006,55(6):1832-1839.
[12] MACISAAC R J, EKINCI E. Progression of diabetickidney disease in the absence of albuminuria[J].DiabetesCare,2019,42(10):1842-1844.
[13] AL-RUBEAAN K, SIDDIQUI K, AI-GHONAIM MA,et al. Assessment of the diagnostic value of differentbiomarkers in relation to various stages of diabeticnephropathy in type 2 diabetic patients[J].ScientificReports,2017,7(1):2684.
[14] 何晓璇, 王刚, 郭炫, 等. FIB，DD 和FDP 在高血压肾损伤中的变化及临床意义[J]. 现代检验医学杂志，2016, 31（2）: 73-76. HE Xiaoxuan, WANG Gang, GUO Xuan, et al. Changesand clinical significance observation on FIB, DD and FDPin renal impairment of hypertension[J].Journal of ModernLaboratory Medicine, 2016, 31（2）: 73-76.
[15] JAMWAL S, SHARMA S. Vascular endotheliumdysfunction: a conservative target in metabolic disorders[J].Imflammation Research,2018,67(5):391-405.
[16] 杜秀娟，曾覃平，张秀梅，等. 血栓弹力图、纤维蛋白原及D- 二聚体检测在恶性肿瘤患者凝血功能评估中的应用[J]. 检验医学与临床，2019，16（16）：2347-2353. DU Xiujuan, ZENG Qinping, ZHANG Xiumei, etal.Clinical application of thrombelastogram,fibrinogen andD-dimer detection in coagulation function evaluation ofpatients with malignant tumors[J]. Laboratory Medicineand Clinic, 2019，16（16）：2347-2353.
[17] DOMINGUETI C P, FóSCOLO R B, DUSSE L M S,et al. Association of different biomarkers of renal functionwith D-dimer levels in patients with type 1 diabetesmellitus (renal biomarkers and D-dimer in diabetes)[J]. Arch Endocrinol Metab,2018,62(1):27-33.
[18] PAPADOPOULOU-MARKETOU N , KANAKA-GANTENBEIN C, MARKETOS N, et al. Biomarkersof diabetic nephropathy: A 2017 update[J]. CritRev Clin Lab Sci,2017,54(5):326-342.
[19] 窦家庆，唐松涛，杨启程，等.2 型糖尿病患者的血管并发症与血糖控制及其危险因素的相互关系[J]。安徽医科大学学报，2017，52（3）：426-430. DOU Jiaqing, TANG Songtao, YANG Qichneg. Therelationship between vascular complications and bloodglucose control and risk factors in patients with type2 diabetes mellitus[J]. Acta Universitis MedicinalisAnhui, 2017, 52（3）: 426-430.
[20] Brownlee M.The Pathobiology of diabetic complications aunifying mechanism[J] Diabetes. 2005,54(6):1615-1625.
[21] MAO Song, XIANG Wei, HUANG Songming, et al.Association between homocysteine status and the riskof nephropathy in type 2 diabetes mellitus[J].Clin ChimActa,2014,431:206-210.
[22] JAMWAL S, Sharma S. Vascular endothelium dysfunction:a conservative target in metabolic disorders[J].Inflammation Research,2018,67(5):391-405.
[23] CHEN Jingyi, YE Zixin, WANG xiufen, et al. Nitric oxidebioavailability dysfunction involves in atherosclerosis[J].Biomed Pharmacother,2018, 97: 423-428.
相似文献/References:
[1]韩登科,房绮梅,谢晋烨,等.2 型糖尿病并发高血压患者血清Fetuin B 水平检测及与Hcy 浓度的相关性研究[J].现代检验医学杂志,2020,35(02):24.[doi:10.3969 ／ j.issn.1671-7414.2020.02.008]
HAN Deng-ke,FANG Qi-mei,XIE Jin-ye,et al.Serum Fetuin B Level in Patients with Type 2 Diabetes Mellitus Complicated withHypertension and Its Correlation with Hcy Concentration were Investigated[J].Journal of Modern Laboratory Medicine,2020,35(04):24.[doi:10.3969 ／ j.issn.1671-7414.2020.02.008]
[2]刘肖瑛,林佩娜,欧阳伟庆,等.2 型糖尿病患者血清sdLDL 和脂类水平及相关性分析[J].现代检验医学杂志,2020,35(03):58.[doi:10.3969/j.issn.1671-7414.2020.03.014]
LIU Xiao-ying,LIN Pei-na,OUYANG Wei-qing,et al.Analysis of Serum sdLDL and Lipid Levels and Their Correlation in
Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2020,35(04):58.[doi:10.3969/j.issn.1671-7414.2020.03.014]
[3]洪雄新,李观强,杨 辉,等.2 型糖尿病患者ABCA1 R219K 基因多态性分布及其与血脂水平的相关性研究[J].现代检验医学杂志,2020,35(04):14.[doi:10.3969/j.issn.1671-7414.2020.04.004]
HONG Xiong-xin,LI Guan-qiang,YANG Hui,et al.Study on Distribution of ABCA1 R219K Gene Polymorphism and Its Correlation with Blood Lipid Levels for Type 2 Diabetes Mellitus Patients[J].Journal of Modern Laboratory Medicine,2020,35(04):14.[doi:10.3969/j.issn.1671-7414.2020.04.004]
[4]骆时木,叶宇宸,欧阳航,等.福建省泉州地区汉族人群TCF7L2 rs11196205基因多态性与T2DM 的相关性研究[J].现代检验医学杂志,2020,35(04):22.[doi:10.3969/j.issn.1671-7414.2020.04.006]
LUO Shi-mu,YE Yu-chen,OUYANG Hang,et al.Correlation between TCF7L2 rs11196205 Gene Polymorphism and Onset Risk of T2DM in Han Population of Quanzhou, Fujian Province[J].Journal of Modern Laboratory Medicine,2020,35(04):22.[doi:10.3969/j.issn.1671-7414.2020.04.006]
[5]杨莉婷,陈 翠,蒋兴亮.2 型糖尿病患者血清残余胆固醇水平与超敏C 反应蛋白表达的相关性研究[J].现代检验医学杂志,2020,35(04):45.[doi:10.3969/j.issn.1671-7414.2020.04.011]
YANG Li-ting,CHEN Cui,JIANG Xing-liang.Association between Serum Remnant Cholesterol Levels and Expression of High Sensitive C-reactive Protein in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):45.[doi:10.3969/j.issn.1671-7414.2020.04.011]
[6]张海霞a,郭 杰a,袁 宁a,等.老年健康体检人群外周血红细胞分布宽度与糖化血红蛋白A1c 的相关性研究[J].现代检验医学杂志,2020,35(04):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
ZHANG Hai-xia a,GUO Jiea,YUAN Ninga,et al.Association of Peripheral Blood Red Blood Cell Distribution Width with Glycated Hemoglobin A1c in the Healthy Elderly Population for Check-ups[J].Journal of Modern Laboratory Medicine,2020,35(04):65.[doi:10.3969/j.issn.1671-7414.2020.04.016]
[7]张 艳a,刘 翔a,李鸿钏a,等.血清脂蛋白磷脂酶A2 和血浆抗凝血酶Ⅲ对2 型糖尿病患者发生缺血性脑卒中风险的评估价值[J].现代检验医学杂志,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
ZHANG Yana,LIU Xianga,LI Hong-chuana,et al.Evaluation Value of Serum Lipoprotein-Associated Phospholipase A2 and Plasma Antithrombin Ⅲ on the Risk of Ischemic Stroke in Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):71.[doi:10.3969/j.issn.1671-7414.2020.04.017]
[8]张 凯,李全双,程 星.2 型糖尿病患者血清低清蛋白水平对糖化清蛋白检测结果的影响[J].现代检验医学杂志,2020,35(04):126.[doi:10.3969/j.issn.1671-7414.2020.04.032]
ZHANG Kai,LI Quan-shuang,CHENG Xing.Effect of Serum Low Albumin Level on the Detection of Glycosylated Albumin in Patients with Type 2 Ddiabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):126.[doi:10.3969/j.issn.1671-7414.2020.04.032]
[9]欧阳清慧,王 冰,杨自力,等.四川省绵阳地区慢性丙型肝炎患者继发2 型糖尿病危险因素分析[J].现代检验医学杂志,2020,35(04):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]
OUYANG Qing-hui,WANG Bing,YANG Zi-li,et al.Analysis of Risk factors of Chronic Hepatitis C Complicated with Type 2 Diabetes Mellitus in Mianyang of Sichuan[J].Journal of Modern Laboratory Medicine,2020,35(04):151.[doi:10.3969/j.issn.1671-7414.2020.04.038]
[10]陈树鑫a,宁 晔a,韩登科b.2 型糖尿病患者血清 Fetuin B 水平与并发下肢动脉粥样硬化性病变的相关性研究[J].现代检验医学杂志,2020,35(06):21.[doi:doi:10.3969/j.issn.1671-7414.2020.06.006]
CHEN Shu-xin a,NING Ye a,HAN Deng-ke b.Relationship between Serum Fetuin B Level and Atherosclerotic Lesions inLower Limb of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2020,35(04):21.[doi:doi:10.3969/j.issn.1671-7414.2020.06.006]